🚨 #ALNEO results published in the #JCO!
The trial met its primary endpoint, supporting the feasibility of perioperative targeted therapy in this setting.
Congratulations to all investigators and participating centers!
ascopubs.org/doi/10.1200/JCO…
13
Alessandro Leonetti retweeted
🔥ALNEO: Neoadjuvant alectinib in potentially resectable stage III ALK+ NSCLC
🆙 @JCO_ASCO @ASCO
🎯MPR 42% (primary endpoint met), pCR 12%
🎯ORR 67%; 85% underwent surgery, R0 in 86%
🎯mFU 26.8 mo: EFS/DFS/OS not reached
🎯Grade ≥3 AEs 9% (neoadjuvant) & 27% (adjuvant)
🎙 @Ale_leonetti
#LCSM @OncoAlert @Larvol @ALKPositiveinc
ascopubs.org/doi/abs/10.1200…
🔄 #ASCO25 REVIEW🔁
☑️#LCSM Rapid Oral, LocReg/SCLC
🔥ALNEO: Alectinib as neoadjuvant treatment in potentially resectable stage III ALK-positive NSCLC
🎙️ Dr. Marcello Tiseo
🎯Surgery 85%, R0 86%,
🎯MPR 46% (15/33), pCR 12% (4/33)
@OncoAlert @ASCO @Larvol
meetings.asco.org/2025-asco-…
Corriamo per #oncorun2026!
Noi oncologi dell’AOU di Parma sosteniamo il valore dell’attività fisica nella prevenzione e cura dei tumori, partecipando a #DonneInCorsa2026, per lo sport, l’equità di genere e la tutela dei diritti.
#AIOM #NICSO
University Hospital of Parma at #WCLC2025 in Barcelona 🇪🇸 with 2 awards, 2 oral presentations and 6 posters!
Proud of our thoracic multidisciplinary group led by Prof @MarcelloTiseo. Good job! 🫁🔬🏆
#LungCancer #Italianresearch
Honored to present the results of the LiBRA study at #WCLC25, focusing on patients with #BRAF V600E–mutant #NSCLC treated with dabrafenib + trametinib.
An important step towards molecular monitoring in this rare NSCLC subset.
#lungcancer #liquidbiopsy #GOIRC
Alessandro Leonetti retweeted
🚨@OncoAlert Hot Off The Press
Just presented @ASCO #ASCO25
Results of #ALNEO phase 2 trial of:
#Neoadjuvant #Alectinib in potentially resectable stage Ill #ALK+ Non-Small Cell #LungCancer
✅pCR: 12%
✅MPR: 46%
✅ORR: 67%
✅Safety profile consistent with previous studies
Alessandro Leonetti retweeted
Italians are everywhere - #WCLC2024 edition @pecci_federica1 @DiFedericoMD @Ale_leonetti @EdoardoGarbo @BiagioRicciutMD @lorenzobellu @dmarinelli93 @RobertoFerrara_
An honor to present the IA results of #ALNEO phII trial of #neoadjuvant #alectinib in potentially resectable stage III #ALK+ #NSCLC at @IASLC #WCLC2024:
➡️ 18 pts included in IA
✅ MPR 39%, pCR 17%, no relevant toxicity
Final analysis on 33 pts awaited!
Happy to share our latest manuscript on liquid biopsy and 18F-FDG PET as noninvasive predictors of 1L #osimertinib outcome in #EGFR-mutated #NSCLC.
Thanks to all the team!
clinical-lung-cancer.com/art…
Alessandro Leonetti retweeted
Best post award for waning effect of adjuvant EGFR TKIs in resected NSCLC. Cochrane Metanalysis Lung Cancer Group. @CochraneLibrary @cochranecollab @MOcchipintiMD @MImbimbo1 @vittoriosimeon @giusvisc
#ELCC24
Alessandro Leonetti retweeted
Wonderful educational section on Liquid Biopsy in clinical practice at the #ELCC24 with an outstanding panel of experts @UmbertoMalapel1 @CharuAggarwalMD Natasha Leighl and T. Mitsudomi @myESMO @IASLC – at Prague, Czech Republic
Our RW study of first-line pembrolizumab plus platinum-pemetrexed in Italian patients with advanced non-squamous lung cancer is out on Eur J Cancer!
➡️ 1068 pts
➡️ mOS 16.1m, mPFS 9.9m, ORR 43.4%
➡️ Favourable outcomes in PD-L1 < 1%
👉 ejcancer.com/article/S0959-8…
Great teamwork!
Check our latest work published in @BrJCancer!
We characterized resistance mechanisms to #osimertinib in paired #tissue and #liquidbiopsy in #EGFRmut #NSCLC. Thanks to the #team for the great work!
➕ nature.com/articles/s41416-0…
1
15
1,199
Alessandro Leonetti retweeted
Intrinsic Resistance to #Osimertinib in EGFR Mutated #NSCLC Cell Lines Induced by Alteration in Cell-Cycle Regulators link.springer.com/article/10…
Alessandro Leonetti retweeted
Congratulations to all the @IASLC Academy Program 2022 & 2023 Recipients! @mkbaine @MarianaBrandao0 @FCortiula @DiFedericoMD @ajuloorimd @MMarmarelis @VMenezesMD @pecci_federica1, @pedrofsrocha @xako22 @drshieldsmd #WCLC23 #LCSM
Alessandro Leonetti retweeted
🚨🔥The future of #ThoracicOncology is in great hands!
The 2023 @IASLC #Academy, for #EarlyCareer #Physicians & #Researchers, meeting at #WCLC23 in Singapore.
Outstanding presentations by amazing members/mentees.
Honored to serve as a faculty along with great colleagues @ChristianRolfo @LuisRaezMD @marinagarassino @AnneTsao2 @JPatelMD @acmoorephd @JackWestMD & others.
#LCSM #LungCancer.
Alessandro Leonetti retweeted
What a fantastic event!
Happy to be part of this group!
Starting the #WCLC23 🇸🇬with our IASLC Academy! Very excited to meet all the future leaders in thoracic oncology! @IASLC @RManochakian @marinagarassino @AnneTsao2 @LuisRaezMD @Piuchagarrido @JPatelMD @JackWestMD @karenkellymd @HwakeleeMD
Alessandro Leonetti retweeted
Great day with the @IASLC Academy participants! #WCLC23 @marinagarassino @RManochakian @UmbertoMalapel1 @Piuchagarrido @triparnasen @karenkellymd @HwakeleeMD @LuisRaezMD @danieltanmd











































